A Single-center, Open-label, Randomized, Two-treatment, Two-period Crossover Trial to Investigate Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2018
At a glance
- Drugs Aripiprazole/sertraline (Primary) ; Aripiprazole; Sertraline
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 27 Aug 2018 Status changed from active, no longer recruiting to completed.
- 22 Feb 2018 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 22 Feb 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Jul 2018.